Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 8/20 | 0.39 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2330968 | 1.00 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL1411286 | 1.00 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL1411254 | 1.00 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL18959857 | 0.91 | CYP3A4 (0.37) | DNM1CA1CA2 | |
| SCHEMBL5163855 | 0.88 | ALDH1A1 (0.32) | DNM1 | |
| Triethylene Glycol SCHEMBL7770640 | 0.86 | MEN1 (0.61) | DNM1LPAR3LPAR1 | |
| SCHEMBL497154 | 0.82 | DNM1 (0.42) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL8605070 | 0.82 | LMNA (0.39) | — | |
| SCHEMBL8542544 | 0.82 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL25544295 | 0.82 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9087223-A | — | — | None | — | — | JP | disclosed |
| US-9365789-B2 | Dialkyl ether, and lubricant base oil and lubricating oil composition containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-14 | — | — | US | disclosed |
| EP-2939998-A1 | DIALKYL ETHER, AND BASE OIL FOR LUBRICANT OILS AND LUBRICANT OIL COMPOSITION EACH CONTAINING SAME | Idemitsu Kosan Co., Ltd (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-20140187459-A1 | DIALKYL ETHER, AND LUBRICANT BASE OIL AND LUBRICATING OIL COMPOSITION CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-03 | — | — | US | disclosed |
| US-7935358-B2 | Cosmetic skin preparation | KAO CORPORATION (JP) | 2011-05-03 | — | — | US | disclosed |
| US-20090035333-A1 | COSMETIC SKIN PREPARATION | KAO CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-1857093-A1 | COSMETIC SKIN PREPARATION | Kao Corporation (JP) | 2007-11-21 | — | — | EP | disclosed |
| CN-1099403-C | Novel ether compound and process for producing the same | KAO CORP (JP) | 2003-01-22 | — | — | CN | disclosed |
| EP-0825972-B1 | NOVEL ETHER COMPOUND AND PROCESS FOR PRODUCING THE SAME | KAO CORP (JP) | 2001-08-16 | — | — | EP | disclosed |
| US-6011071-A | POLYOXYALKYLENE GLYCOL CAPPED AT ONE END WITH AN A-BRANCHED ALKYL GROUP BEARING AN ALPHA-HYDROGEN ATOM, AND AT THE OTHER END WITH A BRANCHED OR STRAIGHT C10-30 CHAIN ALKYL OR ALKENYL GROUP | KAO CORPORATION (JP) | 2000-01-04 | — | — | US | disclosed |
| US-5914430-A | REACTING A HYDROXY COMPOUND AND A CARBONYL COMPOUND UNDER HYDROGEN ATMOSPHERE USING CATALYST, REMOVING WATER | KAO CORPORATION (JP) | 1999-06-22 | — | — | US | disclosed |
| CN-1184461-A | Novel ether compound and process for producing the same | KAO CORP (JP) | 1998-06-10 | — | — | CN | disclosed |
| EP-0825972-A1 | NOVEL ETHER COMPOUND AND PROCESS FOR PRODUCING THE SAME | Kao Corporation (JP) | 1998-03-04 | — | — | EP | disclosed |
| JP-H0987223-A | NEW ETHER COMPOUND AND ITS PRODUCTION | KAO CORP | 1997-03-31 | — | — | JP | disclosed |
| WO-1996036583-A1 | NOVEL ETHER COMPOUND AND PROCESS FOR PRODUCING THE SAME | KAO CORPORATION (JP) | 1996-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035333-A1 | COSMETIC SKIN PREPARATION | CUTA, SERPINH1, FUCA1 | DNM1 4610/4885LPAR3 2876/4885LPAR1 2451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.